Tuberculosis

Reading File
Finding Sources
Searching Images

tuberculosis chest X-ray and pathology

This posteroanterior (PA) chest X-ray demonstrates extensive bilateral pulmonary pathology, highly characteristic of advanced post-primary tuberculosis with superinfection. The left lung field shows a significantly distorted architecture with large, irregular, and oval-shaped lucencies in the upper and middle zones, consistent with pulmonary cavitation. The left lower zone exhibits dense alveolar opacification with visible air bronchograms and spotty shadowing, indicating consolidation. The right lung displays inhomogeneous opacities in the upper and middle lobes, accompanied by volume loss evidenced by the retraction of the right hilum and horizontal fissure. The mediastinal structures appear shifted, and there is visible distortion of the normal hilar anatomy. This diagnostic image illustrates severe parenchymal destruction, cavitary disease, and bilateral infiltrates, which are key clinical markers for evaluating disease severity and treatment response in infectious respiratory medicine.

This posteroanterior (PA) chest X-ray demonstrates extensive bilateral pulmonary pathology, highly characteristic of advanced post-primary tuberculosis with superinfection. The left lung field shows a significantly distorted architecture with large, irregular, and oval-shaped lucencies in the upper and middle zones, consistent with pulmonary cavitation. The left lower zone exhibits dense alveolar opacification with visible air bronchograms and spotty shadowing, indicating consolidation. The right lung displays inhomogeneous opacities in the upper and middle lobes, accompanied by volume loss evidenced by the retraction of the right hilum and horizontal fissure. The mediastinal structures appear shifted, and there is visible distortion of the normal hilar anatomy. This diagnostic image illustrates severe parenchymal destruction, cavitary disease, and bilateral infiltrates, which are key clinical markers for evaluating disease severity and treatment response in infectious respiratory medicine.

This chest X-ray (posteroanterior view) demonstrates significant pulmonary pathology consistent with left lung collapse and architectural distortion, likely as a sequela of pulmonary tuberculosis. Key findings include an opaque left hemithorax with a marked loss of volume (blue arrow), causing a significant ipsilateral shift of the mediastinum and trachea (red arrow). The ribs on the left side appear crowded, further reflecting the volume loss. In contrast, the right lung shows signs of compensatory hyperinflation (yellow arrow), evidenced by increased radiolucency and expanded volume to compensate for the contralateral dysfunction. The cardiac silhouette is obscured by the mediastinal shift and left-sided opacification. This radiological presentation is characteristic of chronic fibro-cavitary changes or total lung collapse, frequently observed in advanced or treated tuberculosis cases, and illustrates the physical pull exerted by parenchymal destruction and scarring on midline structures.

This chest X-ray (posteroanterior view) demonstrates significant pulmonary pathology consistent with left lung collapse and architectural distortion, likely as a sequela of pulmonary tuberculosis. Key findings include an opaque left hemithorax with a marked loss of volume (blue arrow), causing a significant ipsilateral shift of the mediastinum and trachea (red arrow). The ribs on the left side appear crowded, further reflecting the volume loss. In contrast, the right lung shows signs of compensatory hyperinflation (yellow arrow), evidenced by increased radiolucency and expanded volume to compensate for the contralateral dysfunction. The cardiac silhouette is obscured by the mediastinal shift and left-sided opacification. This radiological presentation is characteristic of chronic fibro-cavitary changes or total lung collapse, frequently observed in advanced or treated tuberculosis cases, and illustrates the physical pull exerted by parenchymal destruction and scarring on midline structures.

This diagnostic image is a posteroanterior (PA) chest X-ray illustrating a case of moderately advanced pulmonary tuberculosis. The primary pathology is localized in the right lung field, characterized by disseminated heterogeneous opacities of slight to moderate density. These confluent lesions extend across approximately one-third of the right lung volume. Notably, there are visible radiolucent areas within the opacified regions, indicating the presence of pulmonary cavitation, with the largest cavity measuring less than 4 cm in diameter. The left lung field remains relatively clear with normal bronchovascular markings. The mediastinal silhouette and cardiac contour are within normal limits, and the visible bony structures, including the ribs and clavicles, appear intact. This radiograph serves as a classic educational example for the classification of tuberculosis severity based on the extent of parenchymal involvement and the presence of cavitary disease, demonstrating the typical upper and middle zone predilection of secondary tuberculosis.

This diagnostic image is a posteroanterior (PA) chest X-ray illustrating a case of moderately advanced pulmonary tuberculosis. The primary pathology is localized in the right lung field, characterized by disseminated heterogeneous opacities of slight to moderate density. These confluent lesions extend across approximately one-third of the right lung volume. Notably, there are visible radiolucent areas within the opacified regions, indicating the presence of pulmonary cavitation, with the largest cavity measuring less than 4 cm in diameter. The left lung field remains relatively clear with normal bronchovascular markings. The mediastinal silhouette and cardiac contour are within normal limits, and the visible bony structures, including the ribs and clavicles, appear intact. This radiograph serves as a classic educational example for the classification of tuberculosis severity based on the extent of parenchymal involvement and the presence of cavitary disease, demonstrating the typical upper and middle zone predilection of secondary tuberculosis.

Posteroanterior (PA) chest X-ray demonstrating extensive bilateral pulmonary pathology, highly characteristic of chronic or post-primary pulmonary tuberculosis. The imaging shows widespread, asymmetrical air-space opacities scattered throughout both lung fields, with a greater density and involvement on the right side. Multiple well-defined cavitary lesions are visible, predominantly located in the bilateral upper zones and the right mid-zone (highlighted by red arrows), appearing as radiolucent areas surrounded by thick, irregular walls. In the right lower and upper zones, there is evidence of tractional bronchiectasis (highlighted by white arrows), indicated by tubular lucencies and architectural distortion. The trachea shows a mild shift toward the right, suggesting volume loss or fibrotic changes in the right lung parenchyma. These findings illustrate the chronic sequelae of mycobacterial infection, including lung destruction, cavitation, and secondary airway remodeling.

Posteroanterior (PA) chest X-ray demonstrating extensive bilateral pulmonary pathology, highly characteristic of chronic or post-primary pulmonary tuberculosis. The imaging shows widespread, asymmetrical air-space opacities scattered throughout both lung fields, with a greater density and involvement on the right side. Multiple well-defined cavitary lesions are visible, predominantly located in the bilateral upper zones and the right mid-zone (highlighted by red arrows), appearing as radiolucent areas surrounded by thick, irregular walls. In the right lower and upper zones, there is evidence of tractional bronchiectasis (highlighted by white arrows), indicated by tubular lucencies and architectural distortion. The trachea shows a mild shift toward the right, suggesting volume loss or fibrotic changes in the right lung parenchyma. These findings illustrate the chronic sequelae of mycobacterial infection, including lung destruction, cavitation, and secondary airway remodeling.

Searching PubMed

"tuberculosis"[MeSH Terms] AND "diagnosis OR treatment"

Reading File
Reading File
Searching PubMed

"tuberculosis"[MeSH Terms] AND "treatment"[MeSH Terms]

Reading File
Finding Sources
Reading File
Reading File
I now have comprehensive information from authoritative textbooks. Let me compile the full, detailed response on Tuberculosis.

Tuberculosis (TB)

1. Etiology and Transmission

Tuberculosis is caused by Mycobacterium tuberculosis, an obligate aerobic, non-spore-forming, acid-fast bacillus. It is transmitted via airborne droplet nuclei from close contact with infectious patients. The lung is the primary portal of entry, though any organ can be affected after hematogenous dissemination.

2. Pathogenesis

After inhalation, bacilli are ingested by alveolar macrophages. In most immunocompetent individuals, the immune response contains but does not eliminate the organism - this is latent TB infection (LTBI). If the immune system fails to contain the infection, active TB develops (primary progressive disease). In a second scenario, years or decades later, reactivation of latent bacilli causes post-primary (reactivation) TB.
The hallmark lesion is the granuloma - an organized aggregate of activated macrophages, epithelioid cells, Langhans giant cells, and lymphocytes surrounding a focus of caseous (cheesy) necrosis. When granulomas liquefy and drain into airways, cavitary lesions form, providing the high-oxygen environment ideal for bacillary replication and making the patient infectious.

3. Clinical Presentations

Pulmonary TB (most common)

Typical symptoms:
  • Productive cough (often prolonged >3 weeks)
  • Hemoptysis
  • Fever and night sweats
  • Anorexia and weight loss (hence the historical term "consumption")
  • Fatigue and malaise
Chest X-ray findings:
  • Reactivation TB: Upper lobe cavitary lesions, fibrosis, and scarring
  • Primary TB: Consolidation at the apex of lower lobe or base of upper lobe, with hilar/mediastinal lymphadenopathy
  • Miliary TB: Diffuse 1-2 mm nodular ("millet seed") opacities throughout both lung fields
Below are characteristic chest X-ray findings from clinical TB cases:
Extensive bilateral cavitary pulmonary TB with upper zone predominance
Advanced post-primary TB: bilateral cavitary lesions, consolidation, and architectural distortion with upper zone predominance.
Moderately advanced right-sided pulmonary TB with cavitation
Moderately advanced TB: right upper and middle zone opacities with visible cavitation. Classic example of secondary TB with upper zone predilection.
Chronic post-TB with left lung collapse and mediastinal shift
Late sequela: total left lung collapse with tracheal deviation - a result of chronic fibrotic changes following treated TB.

Extrapulmonary TB (10-25% of cases worldwide)

Occurs more often in children, the elderly, HIV-positive individuals, and the immunosuppressed. Occurs via lymphohematogenous spread:
FormSite / Syndrome
Miliary / DisseminatedWidespread organ seeding (lung, liver, spleen, bone marrow)
Serosal TBTuberculous pleurisy, meningitis, pericarditis, peritonitis, arthritis
Solid organ TBRenal TB, adrenal TB (formerly a common cause of Addison's disease), hepatic TB
Skeletal TBPott's disease (vertebral TB with potential cord compression)
TB meningitisMost dangerous serosal form - difficult to diagnose, can cause permanent brain damage
TB meningitis deserves special mention: PCR on CSF represents a significant advance, with a multiplex PCR achieving 94% sensitivity and 100% specificity for culture-confirmed TB meningitis in small series. - Textbook of Family Medicine 9e
Miliary TB presents subtly; granuloma formation may be absent in HIV-infected individuals, children, pregnant women, or those with alcoholism/liver disease - requiring tissue biopsy for diagnosis.

HIV and TB Co-infection

  • TB may be more severe, with atypical clinical findings
  • Chest X-ray is occasionally normal
  • Rapid molecular-based DST is strongly recommended to guide treatment

Endobronchial TB

Tracheo-bronchial stenosis occurs in up to 90% of patients with endobronchial TB despite adequate treatment. The most common symptom is intractable cough. CT shows circumferential tracheal thickening, deformation of tracheal rings, and stenosis. - Murray & Nadel's Textbook of Respiratory Medicine

4. Diagnosis

Testing for Latent TB Infection (LTBI)

Two main tests:
1. Tuberculin Skin Test (TST / Mantoux / PPD) Intradermal injection of purified protein derivative (PPD); induration read at 48-72 hours.
Cut-off for PositivityPopulation
≥5 mmHIV-positive; recent TB contact; fibrotic changes on CXR consistent with old TB; organ transplant recipients; immunosuppressed
≥10 mmHigh-risk populations (healthcare workers, residents of high-prevalence areas, IV drug users, lab personnel, persons with clinical conditions increasing TB risk)
≥15 mmOtherwise low-risk persons
2. Interferon-Gamma Release Assays (IGRAs)
  • QuantiFERON-TB Gold and T-SPOT.TB
  • Advantages: single blood draw, greater specificity for M. tuberculosis, no anamnestic (booster) response on repeat testing
  • Preferred over TST in BCG-vaccinated populations
A positive result by either method should prompt evaluation for preventive therapy.

Testing for Active TB

  • Sputum smear (AFB microscopy): Rapid but less sensitive; 3 serial morning specimens recommended
  • Sputum culture: Gold standard, takes 2-6 weeks (liquid media) or 4-8 weeks (solid media)
  • Molecular tests (e.g., GeneXpert MTB/RIF): Rapid detection of M. tuberculosis AND rifampin resistance simultaneously - strong recommendation for HIV-positive patients
  • Drug Susceptibility Testing (DST): Mandatory for all previously treated TB patients; focus at least on isoniazid and rifampin sensitivity

5. Treatment

Latent TB Infection (LTBI)

RegimenDurationNotes
Isoniazid (INH)6-9 months~0.6% risk of clinical hepatitis
Rifampin (RIF)4 monthsEffective alternative
Rifampin + Pyrazinamide2 monthsNo longer recommended - excess liver toxicity
Treatment of LTBI is indicated even in BCG-vaccinated patients and is effective in HIV-co-infected patients.

Active Pulmonary TB

Standard 6-month WHO regimen (drug-sensitive, new cases):
  • Intensive phase (months 1-2): Isoniazid (H) + Rifampin (R) + Pyrazinamide (Z) + Ethambutol (E) = HRZE
  • Continuation phase (months 3-6): Isoniazid + Rifampin = HR
Extended 9-month course is used for:
  • Cavitary lesions
  • Persistent positive cultures after 2 months of therapy
Daily therapy is preferred over intermittent twice-weekly therapy, which has been less effective in RCTs.
Monitoring: Repeat cultures should be obtained after 2 months; 80% of patients have negative cultures at this point.

Drug-Resistant TB

  • MDR-TB: Resistant to at least isoniazid AND rifampin. Requires second-line agents (fluoroquinolones, aminoglycosides, bedaquiline, linezolid) for 18-24 months.
  • XDR-TB (Extensively Drug-Resistant): MDR-TB plus resistance to fluoroquinolones and at least one injectable agent.

Directly Observed Therapy (DOT)

Indicated for patients at specific risk for treatment non-compliance. Enhanced DOT strategies (social supports, barrier reduction, compliance monitoring, incentives) appear more effective than standard DOT. The WHO reports an 82% global TB treatment success rate, though MDR-TB prevalence is increasing. - Textbook of Family Medicine 9e

6. Prevention

  • BCG Vaccine: Live attenuated Mycobacterium bovis strain; given at birth in high-prevalence countries. Provides good protection against disseminated TB (miliary, meningitis) in children; less effective against adult pulmonary TB.
  • Infection control: Airborne precautions (negative pressure rooms, N95 respirators) for known or suspected active TB
  • LTBI screening: Targeted testing of high-risk populations (healthcare workers, HIV-infected, close contacts of TB cases, immigrants from high-prevalence countries)
  • Contact investigation: All close contacts of an index case should be screened

7. High-Risk Groups for TB Reactivation

  • HIV/AIDS
  • Diabetes mellitus
  • Chronic renal failure / dialysis
  • Silicosis
  • Malnutrition / low body weight
  • Malignancy, especially head and neck
  • Immunosuppressive therapy (TNF-alpha inhibitors, corticosteroids, post-transplant)
  • Substance abuse (alcohol, IV drugs)
  • Recent TB infection (within 2 years)

Sources

  • Textbook of Family Medicine, 9th Edition (Rakel), Ch. 16
  • Murray & Nadel's Textbook of Respiratory Medicine, Ch. 71
This is a shared conversation. Sign in to Orris to start your own chat.